04.26.16
Francis (Frank) Maddalo has been appointed senior vice president of manufacturing at Cytovance Biologics. Mr. Maddalo will oversee manufacturing and warehouse functions.
Frank Maddalo has more than 30 years of experience manufacturing commercial cGMP products, including manufacturing operations expertise from small molecule drugs to biologics and medical devices. Mr. Maddalo established and operated multiple cGMP commercial-scale manufacturing facilities in the U.S., Australia, The Netherlands, Wales, and Switzerland.
Prior to joining the company, Mr. Maddalo was vice president Operations/Manufacturing at Perosphere, Inc., where he completed the construction of a 20,000 sq.-ft. API manufacturing facility for small molecule drug substance and drug product, including compounding, fill finish, packaging, labeling, shipping and storage. His previous experience includes DSM Biologics, CR Bard, Serono Labs, and Verax Biomedical.
"Frank is the ideal candidate for this position. His extensive experience with both clinical and commercial biologics manufacturing, along with his years of working in process development and validation with site qualifications, makes him an invaluable asset to Cytovance's Leadership team," said chief executive officer Darren Head.
Frank Maddalo has more than 30 years of experience manufacturing commercial cGMP products, including manufacturing operations expertise from small molecule drugs to biologics and medical devices. Mr. Maddalo established and operated multiple cGMP commercial-scale manufacturing facilities in the U.S., Australia, The Netherlands, Wales, and Switzerland.
Prior to joining the company, Mr. Maddalo was vice president Operations/Manufacturing at Perosphere, Inc., where he completed the construction of a 20,000 sq.-ft. API manufacturing facility for small molecule drug substance and drug product, including compounding, fill finish, packaging, labeling, shipping and storage. His previous experience includes DSM Biologics, CR Bard, Serono Labs, and Verax Biomedical.
"Frank is the ideal candidate for this position. His extensive experience with both clinical and commercial biologics manufacturing, along with his years of working in process development and validation with site qualifications, makes him an invaluable asset to Cytovance's Leadership team," said chief executive officer Darren Head.